EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

From Genome to Phenotype: Genetic and epigenetic biomarkers in autism spectrum disorder and their clinical applications

Verena Coelho Lobão Azevedo, Maria Gabriela da Rocha Florêncio, Samarina Pompeu Braga Gonçalves Sarquis, Luana Serra Lage, Marília Helena Melo Carralas Lobato, Nalinny Coelho de Brito, Renata Alves Dias, Paula Jordana Maia da Silva, Bernard Cainã Ferreira Neves, Edge Biffi Teixeira Scarparo, Luciana Rodrigues de Araújo, Paulo José Marques de Sousa Neto und 5 weitere

International Health Sciences Review · 20.04.2026 · 2 (2)

DOI: 10.70164/ihsr.v2i2.157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Health Sciences Review, online erschienen am 20.04.2026. Verfasst von Verena Coelho Lobão Azevedo und 16 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Autism Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental condition influenced by complex interactions between genetic and epigenetic factors, resulting in diverse phenotypic manifestations. The identification of molecular biomarkers has emerged as a promising approach to improve diagnosis and clinical management. Methodology: This integrative literature review was conducted using PubMed, SciELO, LILACS, MEDLINE, and Google Scholar, including studies published between 2021 and 2025 in English, Portuguese, and Spanish. Eligible studies addressed genetic and/or epigenetic biomarkers in ASD and their clinical applications. Results and Discussion: Seventeen studies were included. Evidence indicates that ASD involves both rare genetic variants and polygenic risk. Epigenetic mechanisms, such as DNA methylation and microRNAs, contribute to gene expression regulation and phenotype modulation. The integration of multi-omics data has improved biomarker identification, although challenges in validation remain.

Conclusion

Genetic and epigenetic biomarkers demonstrate potential for early diagnosis and personalized approaches in ASD; however, further studies are needed to ensure their clinical applicability.

Zitieren

APA

Azevedo, V. C. L., Florêncio, M. G. D. R., Sarquis, S. P. B. G., Lage, L. S., Lobato, M. H. M. C., Brito, N. C. D., Dias, R. A., Silva, P. J. M. D., Neves, B. C. F., Scarparo, E. B. T., Araújo, L. R. D., Neto, P. J. M. D. S., Rocha, M. B. F. D., Miranda, R. S., Moriya, M. D. A., Araújo, J. R. D., & Guimarães, M. C. M. (2026). From Genome to Phenotype: Genetic and epigenetic biomarkers in autism spectrum disorder and their clinical applications. International Health Sciences Review, 2(2). https://doi.org/10.70164/ihsr.v2i2.157

Vancouver

Azevedo VCL, Florêncio MGDR, Sarquis SPBG, Lage LS, Lobato MHMC, Brito NCD, et al. From Genome to Phenotype: Genetic and epigenetic biomarkers in autism spectrum disorder and their clinical applications. International Health Sciences Review. 2026;2(2). doi:10.70164/ihsr.v2i2.157

BibTeX
@article{Azevedo2026,
  author = {Azevedo, Verena Coelho Lobão and Florêncio, Maria Gabriela da Rocha and Sarquis, Samarina Pompeu Braga Gonçalves and Lage, Luana Serra and Lobato, Marília Helena Melo Carralas and Brito, Nalinny Coelho de and Dias, Renata Alves and Silva, Paula Jordana Maia da and Neves, Bernard Cainã Ferreira and Scarparo, Edge Biffi Teixeira and Araújo, Luciana Rodrigues de and Neto, Paulo José Marques de Sousa and Rocha, Mário Bernardo Farias da and Miranda, Rebeca Silva and Moriya, Marjorie de Almeida and Araújo, Juliana Rodrigues de and Guimarães, Márcia Cristina Monteiro},
  title = {From Genome to Phenotype: Genetic and epigenetic biomarkers in autism spectrum disorder and their clinical applications},
  journal = {International Health Sciences Review},
  year = {2026},
  volume = {2},
  number = {2},
  doi = {10.70164/ihsr.v2i2.157}
}
Kostenlos starten →